[1]
2025. Activation of MIPEP Using CRISPR-Cas9 for Mitochondrial Stability and Telomere Preservation: A Novel In Silico Approach to Age-related Type-II Diabetes Treatment and Ageing. Physical Education, Health and Social Sciences. 3, 3 (Sep. 2025), 126–148. DOI:https://doi.org/10.63163/jpehss.v3i3.678.